• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌的转化治疗以改善中晚期治疗策略。

Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages.

作者信息

Giorgio Antonio, De Luca Massimo

机构信息

Athena Clinic Center, Via Matese, Piedimonte Matese (CE) 81016, Campania, Italy.

Liver Unit, AORN Cardarelli, Via A. Cardarelli, Napoli 80131, Campania, Italy.

出版信息

World J Clin Cases. 2024 Oct 6;12(28):6241-6243. doi: 10.12998/wjcc.v12.i28.6241.

DOI:10.12998/wjcc.v12.i28.6241
PMID:39371556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11362885/
Abstract

This manuscript is based on a case reported by Song published in the . Several challenges remain in the field of hepatocellular carcinoma (HCC) conversion therapy. Consequently, only a limited number of patients with HCC accompanied by portal vein tumor thrombosis (PVTT) and hepatic vein tumor thrombosis (HVTT) are eligible for resection. This clinical case demonstrates that considering the complexity of the disease, a multimodal and multidisciplinary approach is essential for managing HCC accompanied by PVTT and HVTT. However, the outcomes of such surgeries remain controversial. In conclusion, research on HCC conversion therapy is extremely useful for improving treatment strategies for intermediate and advanced HCC, which currently have disappointing clinical outcomes.

摘要

本手稿基于宋发表在……上报告的一个病例。肝细胞癌(HCC)转化治疗领域仍存在若干挑战。因此,仅有有限数量伴有门静脉癌栓(PVTT)和肝静脉癌栓(HVTT)的HCC患者适合进行手术切除。该临床病例表明,鉴于疾病的复杂性,多模式和多学科方法对于管理伴有PVTT和HVTT的HCC至关重要。然而,此类手术的结果仍存在争议。总之,HCC转化治疗的研究对于改善中晚期HCC的治疗策略极为有用,目前中晚期HCC的临床结果令人失望。

相似文献

1
Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages.肝细胞癌的转化治疗以改善中晚期治疗策略。
World J Clin Cases. 2024 Oct 6;12(28):6241-6243. doi: 10.12998/wjcc.v12.i28.6241.
2
Treatment for hepatocellular carcinoma with tumor thrombosis in the hepatic vein or inferior vena cava: A comprehensive review.肝静脉或下腔静脉肿瘤血栓形成的肝细胞癌治疗:综述
World J Gastrointest Surg. 2021 Aug 27;13(8):796-805. doi: 10.4240/wjgs.v13.i8.796.
3
Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance.肝细胞癌患者肝静脉肿瘤血栓:发生率和临床意义。
United European Gastroenterol J. 2021 Jun;9(5):590-597. doi: 10.1002/ueg2.12098. Epub 2021 Jun 2.
4
Robot Assisted Laparoscopy Combined with Thoracoscopy in the Treatment of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus.机器人辅助腹腔镜联合胸腔镜治疗肝癌合并下腔静脉癌栓。
Ann Surg Oncol. 2023 Sep;30(9):5447-5449. doi: 10.1245/s10434-023-13512-5. Epub 2023 Jun 7.
5
Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report.索凡替尼联合贝伐珠单抗治疗后成功转化的肝细胞癌合并门静脉癌栓患者行转化手术:一例报告
World J Surg Oncol. 2022 Jul 12;20(1):228. doi: 10.1186/s12957-022-02691-2.
6
Conversion therapy of a giant hepatocellular carcinoma with portal vein thrombus and inferior vena cava thrombus: A case report and review of literature.巨大肝细胞癌伴门静脉血栓和下腔静脉血栓的转化治疗:1例报告并文献复习
World J Clin Cases. 2024 Jun 6;12(16):2847-2855. doi: 10.12998/wjcc.v12.i16.2847.
7
Prognostic model for identifying candidates for hepatectomy among patients with hepatocellular carcinoma and hepatic vein invasion.用于识别伴有肝静脉侵犯的肝细胞癌患者肝切除术候选者的预测模型。
Br J Surg. 2020 Jun;107(7):865-877. doi: 10.1002/bjs.11524. Epub 2020 Apr 4.
8
Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.索拉非尼联合肝切除术后下腔静脉肿瘤血栓形成的肝细胞癌患者的无复发生存期
Int Surg. 2015 May;100(5):908-14. doi: 10.9738/INTSURG-D-14-00133.1.
9
Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis.门静脉/肝静脉肿瘤血栓形成的肝细胞癌患者的手术策略
PLoS One. 2015 Jun 15;10(6):e0130021. doi: 10.1371/journal.pone.0130021. eCollection 2015.
10
Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case.肝动脉灌注化疗后出现肝静脉肿瘤血栓形成和肾功能不全的晚期肝细胞癌经带主动静脉转流的肝切除术有效治疗:病例报告
BMC Cancer. 2016 Sep 1;16(1):705. doi: 10.1186/s12885-016-2749-4.

引用本文的文献

1
Conversion resection of initially unresectable hepatocellular carcinoma associated with steatohepatitis through hepatic artery infusion chemotherapy-transarterial chemoembolization and systemic therapy: a case report.经肝动脉灌注化疗-经动脉化疗栓塞及全身治疗实现初始不可切除的脂肪性肝炎相关肝细胞癌的转化性切除:病例报告
J Gastrointest Oncol. 2025 Feb 28;16(1):301-308. doi: 10.21037/jgo-24-640. Epub 2025 Feb 26.

本文引用的文献

1
Conversion therapy of a giant hepatocellular carcinoma with portal vein thrombus and inferior vena cava thrombus: A case report and review of literature.巨大肝细胞癌伴门静脉血栓和下腔静脉血栓的转化治疗:1例报告并文献复习
World J Clin Cases. 2024 Jun 6;12(16):2847-2855. doi: 10.12998/wjcc.v12.i16.2847.
2
Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities.精准医学时代晚期肝细胞癌的转化治疗:现状、挑战与机遇。
Cancer Sci. 2024 Jul;115(7):2159-2169. doi: 10.1111/cas.16194. Epub 2024 May 2.
3
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
4
Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review.伴有血管侵犯的晚期肝细胞癌的转化治疗:全面综述。
Front Immunol. 2023 Apr 26;14:1073531. doi: 10.3389/fimmu.2023.1073531. eCollection 2023.
5
Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides.门静脉肿瘤血栓形成与肝细胞癌——变化的趋势
J Hepatocell Carcinoma. 2021 Sep 7;8:1089-1115. doi: 10.2147/JHC.S318070. eCollection 2021.
6
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
7
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
8
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).肝细胞癌诊疗指南(2019年版)
Liver Cancer. 2020 Dec;9(6):682-720. doi: 10.1159/000509424. Epub 2020 Nov 11.